The World Health Organization (WHO) has recommended new guidelines, which suggest earlier drug intervention for HIV and AIDS treatment. The WHO hopes these new guidelines will increase the likelihood that those patients afflcited with the disease in developing countries will be more likely to receive treatment. BBC reports:
New guidelines for HIV treatment could see millions more people in developing countries getting life-saving medicine.
The World Health Organization (WHO) is recommending that patients start taking medication at a much earlier stage of the disease.
The WHO says the guidelines, which are being launched at an international Aids conference in Kuala Lumpur, could help avert an extra 3m Aids deaths by 2025.
The charity MSF welcomed the move - but said extra investment would be needed.
A single pill combining three drugs will be given to people who are HIV positive much earlier, while their immune systems are still strong. Algeria, Argentina and Brazil are already doing this.
Read the full story here: http://bbc.in/10sapFG
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
Community Outreach Is Enabling CeSHHAR to Close HIV Care Gaps in Zimbabwe
April 6th 2021The Centre for Sexual Health and HIV/AIDS Research Zimbabwe conducts evidence-based research related to HIV and AIDS, as well as provides and implements sexual and reproductive health education and interventions among sex workers, children, and adolescents, and in the area of masculinity.
Listen
Challenges, Adaption Needed in Conducting Research for Homeless Youth Living With HIV
April 8th 2024HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.
Read More